Volume 16, Issue 3 (June 2022)
Qom Univ Med Sci J 2022, 16(3): 250-261 |
Back to browse issues page
Research code: IR.MUQ.REC.1399.238
Ethics code: IR.MUQ.REC.1399.238
Maryam Derakhshani1 
, Abolfazl Mohammadbeigi2 , Narges Mohammad Salehi3 , Masoumeh Ebadi4 , Faride Yousefizadeh * 5
, Abolfazl Mohammadbeigi2 , Narges Mohammad Salehi3 , Masoumeh Ebadi4 , Faride Yousefizadeh * 5
1- Department of Anesthesiology, Shahid Beheshti Hospital, Qom University of Medical Sciences, Qom, Iran.
2- Department of Epidemiology and Biostatistics, Research center for Environmental pollutants, Faculty of Health, Qom University of Medical Sciences, Qom, Iran.
3- Department of Epidemiology and Biostatistics, Faculty of Health, Qom University of Medical Sciences, Qom, Iran.
4- Student Research Committee, Department of Epidemiology and Biostatistics, Faculty of Health, Qom University of Medical Sciences, Qom, Iran.
5- Department of Nursing, Faculty of Nursing and Midwifery, Qom University of Medical Sciences, Qom, Iran. ,yousefi.faride@yahoo.com
2- Department of Epidemiology and Biostatistics, Research center for Environmental pollutants, Faculty of Health, Qom University of Medical Sciences, Qom, Iran.
3- Department of Epidemiology and Biostatistics, Faculty of Health, Qom University of Medical Sciences, Qom, Iran.
4- Student Research Committee, Department of Epidemiology and Biostatistics, Faculty of Health, Qom University of Medical Sciences, Qom, Iran.
5- Department of Nursing, Faculty of Nursing and Midwifery, Qom University of Medical Sciences, Qom, Iran. ,
Abstract: (712 Views)
Background and Objectives: Vaccines are one of the most effective medicines available to prevent infectious diseases and their complications. Vaccination coverage information can provide evidence of the success of immunization program as well as the areas where coverage needs to be improved. This study aims to determine the immunization coverage for vaccine-preventable diseases in Iran over a period of 10 years compared to the level recommended by the World Health Organization (WHO).
Methods: This is a systematic review. A structured search for finding related studies from 2011 to 2021 was conducted in two national databases (SID, Irandoc) and four international databases (WOS, PubMed, Scopus and Google Scholar ). Immunization coverage in Iran was compared with the level set in the Immunization Agenda 2030.
Results: Initial search yielded 148 articles. After removing duplicates, 68 articles remained. After screening based on the inclusion criteria, 7 eligible articles were finally selected for the review. The results of the studies showed that the lowest overall immunization coverage was 96.8% and the highest overall immunization coverage was 98.6%. Except for the measles-mumps-rubella vaccine whose coverage was 84.7%, the coverage of all types of vaccines was above 90%
Conclusion: The immunization coverage for vaccine-preventable diseases in Iran is optimal and even higher than the level recommended by the WHO. Currently, vaccination coverage in Iran is within the scope of the goals set in the Immunization Agenda 2030.
Methods: This is a systematic review. A structured search for finding related studies from 2011 to 2021 was conducted in two national databases (SID, Irandoc) and four international databases (WOS, PubMed, Scopus and Google Scholar ). Immunization coverage in Iran was compared with the level set in the Immunization Agenda 2030.
Results: Initial search yielded 148 articles. After removing duplicates, 68 articles remained. After screening based on the inclusion criteria, 7 eligible articles were finally selected for the review. The results of the studies showed that the lowest overall immunization coverage was 96.8% and the highest overall immunization coverage was 98.6%. Except for the measles-mumps-rubella vaccine whose coverage was 84.7%, the coverage of all types of vaccines was above 90%
Conclusion: The immunization coverage for vaccine-preventable diseases in Iran is optimal and even higher than the level recommended by the WHO. Currently, vaccination coverage in Iran is within the scope of the goals set in the Immunization Agenda 2030.
Keywords: Vaccination coverage, BCG vaccine, Measles-mumps-rubella vaccine, Diphtheria-tetanus-pertussis vaccine, Polio vaccine
Type of Study: Review Article |
Subject:
بهداشت عمومی
Received: 2022/08/2 | Accepted: 2022/09/3 | Published: 2022/09/1
Received: 2022/08/2 | Accepted: 2022/09/3 | Published: 2022/09/1
References
1. Sarker AR, Akram R, Ali N, Chowdhury ZI, Sultana M. Coverage and determinants of full immunization: Vaccination coverage among Senegalese children. Medicina. 2019; 55(8):480. [DOI:10.3390/medicina55080480] [PMID] [PMCID] [DOI:10.3390/medicina55080480]
2. MacDonald N, Mohsni E, Al-Mazrou Y, Kim Andrus J, Arora N, Elden S, et al. Global vaccine action plan lessons learned I: Recommendations for the next decade. Vaccine. 2020; 38(33):5364-71. [DOI:10.1016/j.vaccine.2020.05.003] [PMID] [PMCID] [DOI:10.1016/j.vaccine.2020.05.003]
3. Hosseninasab A, Ebrahimpour M, Dehaghani A, Noormandi MM. [Evaluating the immunogenicity of the pertussis component of the DPT vaccine in 12-month old infants in Kerman City (Persian)]. 2015. Health Dev J. 2017; 6(3):228-35. [Link]
4. Mirahmadizadeh AR, Zahmatkesh S, Kashfi Nezhad MS, Sayadi M, Tabatabaee HR, Mokhtari A. [Vaccination coverage in children of Fars Province, 2017: Achievement of global vaccine action plan goals (Persian). Sadra Med Sci J. 2018; 6(4):251-60. [Link]
5. Hvass AMF, Wejse C. High coverage of polio immunization program in refugees resettling in Denmark. A cross-sectional study of polio serology in newly arrived refugees. Expert Rev Vaccines. 2019; 18(12):1317-22. [DOI:10.1080/14760584.2019.1698953] [PMID] [DOI:10.1080/14760584.2019.1698953]
6. Izadi S, Mokhtari-Azad T, Zahraei SM. Measles vaccination coverage and seroprevalence of anti-measles antibody in south-east Islamic Republic of Iran. East Mediterr Health J. 2015; 21(6):396-402. [DOI:10.26719/2015.21.6.396] [PMID] [DOI:10.26719/2015.21.6.396]
7. Zahraei SM, Eshrati B, Gouya MM, Mohammadbeigi A, Kamran A. Is there still an immunity gap in high-level national immunization coverage, Iran? Arch Iran Med. 2014; 17(10):698-701. [PMID]
8. Zahraei SM, Izadi S, Gouya MM, Shahri SMH, Mohammadi M. Immunization coverage of children aged 24-35 months in the Islamic Republic of Iran: A national cluster coverage survey. East Mediterr Health J. 2022; 28(2):121-9. [DOI:10.26719/emhj.21.059] [PMID] [DOI:10.26719/emhj.21.059]
9. Nikfarjam A, Shamshiri A, Hasanpour Z, Khalili M. [Status of vaccination coverage in children 24 months to 6 years in urban and high risk areas covered by Tehran University of Medical Sciences (Persian)]. Iran J Epidemol. 2016; 11(4):10-9. [Link]
10. Khan AI, Islam MT, Siddique SA, Ahmed S, Sheikh N, Siddik AU, et al. Post-vaccination campaign coverage evaluation of oral cholera vaccine, oral polio vaccine and measles-rubella vaccine among forcibly displaced Myanmar nationals in Bangladesh. Hum Vaccin Immunother. 2019; 15(12):2882-6. [DOI:10.1080/21645515.2019.1616502] [PMID] [PMCID] [DOI:10.1080/21645515.2019.1616502]
11. Pezzotti P, Bellino S, Prestinaci F, Iacchini S, Lucaroni F, Camoni L, et al. The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900-2015. Vaccine. 2018; 36(11):1435-43. [DOI:10.1016/j.vaccine.2018.01.065] [PMID] [DOI:10.1016/j.vaccine.2018.01.065]
12. Hill HA, Yankey D, Elam-Evans LD, Singleton JA, Pingali SC, Santibanez TA. Vaccination coverage by age 24 months among children born in 2016 and 2017-national immunization survey-child, United States, 2017-2019. MMWR Morb Mortal Wkly Rep. 2020; 69(42):1505-11. [DOI:10.15585/mmwr.mm6942a1] [PMID] [PMCID] [DOI:10.15585/mmwr.mm6942a1]
13. Gooya M, Khademi N, Ramazani R, Mohammadi N, Laghai Z, Chegeni M, et al. [Vaccination coverage among Nomads' under 6 years children in Kermanshah Province, 2012-2013 (Persian)]. Hakim. 2015; 17(4):337-42. [Link]
14. Haque M, Islam T, Rahman NAA, McKimm J, Abdullah A, Dhingra S. Strengthening primary health-care services to help prevent and control long-term (chronic) non-communicable diseases in low-and middle-income countries. Risk Manag Healthc Policy. 2020; 13:409-26. [DOI:10.2147/rmhp.s239074] [PMID] [PMCID] [DOI:10.2147/RMHP.S239074]
15. Carter A, Msemburi W, Sim SY, AM Gaythorpe K, Lindstrand A, Hutubessy RC. Modeling the impact of vaccination for the immunization agenda 2030: Deaths averted due to vaccination against 14 pathogens in 194 countries from 2021-2030. 2021. [Unpublished article]. [DOI:10.2139/ssrn.3830781] [DOI:10.2139/ssrn.3830781]
16. Zahraei SM, Gouya MM, Mohammadi M, Tabatabaei SM, Zanganeh M, Zareban I, et al. A survey on measles and rubella supplementary immunization activities (SIAs) in Iran. Health Scope. 2017; 6(4):e64184. [DOI:10.5812/jhealthscope.64184] [DOI:10.5812/jhealthscope.64184]
17. Sayehmiri K, Azami M, Nikpey S, Borji M, Sayehmiri F. [Hepatitis B vaccination coverage in health personnel of Iran: A systematic review and meta-analysis study (Persian)]. Iran J Epidemiol. 2015; 11(3)1-10. [Link]
18. Rafiee M, Jahangiri-rad M, Sofi-karimi F. [Analysis of sustainable development indices in Iran: Population and health sections (Persian)]. J Environ Health Eng. 2019; 6(3):265-80. [DOI:10.29252/jehe.6.3.265] [DOI:10.29252/jehe.6.3.265]
19. Bechini A, Boccalini S, Ninci A, Zanobini P, Sartor G, Bonaccorsi G, et al. Childhood vaccination coverage in Europe: Impact of different public health policies. Expert Rev Vaccines. 2019; 18(7):693-701. [DOI:10.1080/14760584.2019.1639502] [PMID] [DOI:10.1080/14760584.2019.1639502]
20. Chard AN, Gacic-Dobo M, Diallo MS, Sodha SV, Wallace AS. Routine vaccination coverage-worldwide, 2019. MMWR Morb Mortal Wkly Rep. 2020; 69(45):1706-10. [DOI:10.15585/mmwr.mm6945a7] [PMID] [PMCID] [DOI:10.15585/mmwr.mm6945a7]
21. Hosseinalipour SA, Mohammadbeigi A, Mohebi S, Saghafipour A, Arabshahi A, Mahdianpour F. Measles elimination successful and its relevant challenges in Iran. Int J Prev Med. 2022; 13:52. [DOI:10.4103/ijpvm.ijpvm_334_20] [PMID] [PMCID] [DOI:10.4103/ijpvm.IJPVM_334_20]
22. Jadidi R, Mohammadbeigi A, Mohammadsalehi N, Ansari H, Ghaderi E. Inequity in timeliness of MMR vaccination in children living in the suburbs of Iranian Cities. Int J Biomed Sci. 2015; 11(2):93-8. [PMID] [PMCID]
23. Mohammadbeigi A, Mokhtari M, Zahraei SM, Eshrati B, Rejali M. Survival analysis for predictive factors of delay vaccination in Iranian children. Int J Prev Med. 2015; 6:119. [DOI:10.4103/2008-7802.170868] [PMID] [PMCID] [DOI:10.4103/2008-7802.170868]
24. Mohammadbeigi A, Zahraei SM, Sabouri A, Asgarian A, Afrashteh S, Ansari H. [The spatial analysis of annual measles incidence and transition threat assessment in Iran in 2016 (Persian)]. Med J Islam Repub Iran. 2019; 33:130. [DOI:10.34171/mjiri.33.130] [PMID] [PMCID]
25. Rejali M, Mohammadbeigi A, Mokhtari M, Zahraei SM, Eshrati B. Timing and delay in children vaccination; evaluation of expanded program of immunization in outskirt of Iranian cities. J Res Health Sci. 2015; 15(1):54-8. [Link]
26. Takhsha N, Taherpour M, Asadi M, Arab Taheri M. [MMR and DTP vaccination side effects in children under 18 months in Bojnurd (Persian)]. J North Khorasan Univ Med Sci. 2015; 6(4):745-53. [DOI:10.29252/jnkums.6.4.745] [DOI:10.29252/jnkums.6.4.745]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |